PortfoliosLab logoPortfoliosLab logo
IDNA vs. IAU
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IDNA vs. IAU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and iShares Gold Trust (IAU). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IDNA achieves a 9.51% return, which is significantly higher than IAU's 4.00% return.


IDNA

1D
-2.18%
1M
-2.18%
YTD
9.51%
6M
10.53%
1Y
41.74%
3Y*
6.48%
5Y*
-8.26%
10Y*

IAU

1D
0.18%
1M
-2.65%
YTD
4.00%
6M
6.47%
1Y
32.38%
3Y*
31.72%
5Y*
18.82%
10Y*
13.42%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IDNA vs. IAU - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
IDNA
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
9.51%17.26%-0.72%-7.63%-42.28%-3.98%54.30%20.83%
IAU
iShares Gold Trust
4.00%63.95%26.85%12.84%-0.63%-4.00%25.03%13.02%

Correlation

The correlation between IDNA and IAU is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.26

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (5Y)
Calculated over the trailing 5-year period

0.15

Correlation (All Time)
Calculated using the full available price history since Jun 14, 2019

0.14

The correlation between IDNA and IAU shifts across timeframes, from 0.14 (all time) to 0.26 (1 year), reflecting how their relationship changes across market environments.

IDNA vs. IAU - Sectors Allocation Comparison


Sectors
IDNA
IAU

Healthcare

97.8%

-

Industrials

0.4%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

-

Real Estate

-

100.0%

Technology

-

-

Utilities

-

-

Healthcare

IDNA
97.8%
IAU

-

Industrials

IDNA
0.4%
IAU

-

Basic Materials

IDNA

-

IAU

-

Communication Services

IDNA

-

IAU

-

Consumer Cyclical

IDNA

-

IAU

-

Consumer Defensive

IDNA

-

IAU

-

Energy

IDNA

-

IAU

-

Financial Services

IDNA

-

IAU

-

Real Estate

IDNA

-

IAU
100.0%

Technology

IDNA

-

IAU

-

Utilities

IDNA

-

IAU

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IDNA vs. IAU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IDNA
IDNA Risk / Return Rank: 5757
Overall Rank
IDNA Sharpe Ratio Rank: 4949
Sharpe Ratio Rank
IDNA Sortino Ratio Rank: 5050
Sortino Ratio Rank
IDNA Omega Ratio Rank: 4343
Omega Ratio Rank
IDNA Calmar Ratio Rank: 7979
Calmar Ratio Rank
IDNA Martin Ratio Rank: 6464
Martin Ratio Rank

IAU
IAU Risk / Return Rank: 3434
Overall Rank
IAU Sharpe Ratio Rank: 3434
Sharpe Ratio Rank
IAU Sortino Ratio Rank: 3030
Sortino Ratio Rank
IAU Omega Ratio Rank: 3737
Omega Ratio Rank
IAU Calmar Ratio Rank: 3737
Calmar Ratio Rank
IAU Martin Ratio Rank: 3131
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IDNA vs. IAU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and iShares Gold Trust (IAU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IDNAIAUDifference

Sharpe ratio

Return per unit of total volatility

1.71

1.23

+0.48

Sortino ratio

Return per unit of downside risk

2.48

1.63

+0.85

Omega ratio

Gain probability vs. loss probability

1.28

1.25

+0.03

Calmar ratio

Return relative to maximum drawdown

4.09

1.87

+2.23

Martin ratio

Return relative to average drawdown

11.79

4.69

+7.10

IDNA vs. IAU - Sharpe Ratio Comparison

The current IDNA Sharpe Ratio is 1.71, which is higher than the IAU Sharpe Ratio of 1.23. The chart below compares the historical Sharpe Ratios of IDNA and IAU, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


IDNAIAUDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.71

1.23

+0.48

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.29

1.05

-1.35

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.85

Sharpe Ratio (All Time)

Calculated using the full available price history

0.10

0.63

-0.53

Drawdowns

IDNA vs. IAU - Drawdown Comparison

The maximum IDNA drawdown since its inception was -68.26%, which is greater than IAU's maximum drawdown of -45.14%. Use the drawdown chart below to compare losses from any high point for IDNA and IAU.


Loading charts...

Drawdown Indicators


IDNAIAUDifference

Max Drawdown

Largest peak-to-trough decline

-68.26%

-45.14%

-23.12%

Max Drawdown (1Y)

Largest decline over 1 year

-10.66%

-19.18%

+8.52%

Max Drawdown (3Y)

Largest decline over 3 years

-29.73%

-19.18%

-10.55%

Max Drawdown (5Y)

Largest decline over 5 years

-68.26%

-20.93%

-47.33%

Max Drawdown (10Y)

Largest decline over 10 years

-21.82%

Current Drawdown

Current decline from peak

-46.01%

-16.88%

-29.13%

Average Drawdown

Average peak-to-trough decline

-36.24%

-15.96%

-20.28%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.70%

7.63%

-3.93%

Volatility

IDNA vs. IAU - Volatility Comparison

iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) has a higher volatility of 7.24% compared to iShares Gold Trust (IAU) at 5.78%. This indicates that IDNA's price experiences larger fluctuations and is considered to be riskier than IAU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IDNAIAUDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.24%

5.78%

+1.46%

Volatility (6M)

Calculated over the trailing 6-month period

18.21%

23.00%

-4.79%

Volatility (1Y)

Calculated over the trailing 1-year period

24.51%

26.51%

-2.00%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

28.42%

17.96%

+10.46%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

29.53%

15.90%

+13.63%

IDNA vs. IAU - Expense Ratio Comparison

IDNA has a 0.47% expense ratio, which is higher than IAU's 0.25% expense ratio.


Dividends

IDNA vs. IAU - Dividend Comparison

IDNA's dividend yield for the trailing twelve months is around 1.08%, while IAU has not paid dividends to shareholders.


PositionTTM2025202420232022202120202019
IAU
iShares Gold Trust
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
IDNA
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
1.08%1.18%0.98%1.04%0.54%0.70%0.26%0.80%

Frequently Asked Questions


IDNA and IAU have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IDNA has higher volatility (7.24%) compared to IAU (5.78%). In terms of maximum drawdown, IDNA dropped -68.26% vs IAU's -45.14%.

On 5-year performance, IAU leads with 18.82% vs -8.26% for IDNA. On fees, IAU is cheaper at 0.25% per year. On volatility, IAU has been the lower-risk option at 5.78%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, IAU has performed better with a 18.82% return vs -8.26%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

IAU is cheaper with a 0.25% expense ratio, compared with 0.47% for IDNA.

IDNA has the higher dividend yield at 1.08%, compared with 0.00% for IAU.

IDNA is categorized as Health & Biotech Equities, while IAU is Gold. IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index, while IAU tracks LBMA Gold Price. Their fees differ too: 0.47% for IDNA and 0.25% for IAU.

IDNA currently has the higher Sharpe Ratio (1.71 vs 1.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IDNA and IAU

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer